Ā | Ghana | Madagascar | KuskalāWallis | Dunnās post test | |||||
---|---|---|---|---|---|---|---|---|---|
Female (A) | Male (B) | Female (C) | Male (D) | p (A vs. B) | p (C vs. D) | P (A vs. C) | P (B vs. D) | ||
Age (years,Ā Ā±Ā SD) | 32.2Ā Ā±Ā 7.4 | 29.2Ā Ā±Ā 4.7 | 37.5Ā Ā±Ā 5.1 | 38.7Ā Ā±Ā 5.7 | <0.0001 | 0.1617 | >0.9999 | 0.001 | <0.0001 |
AMA1 (AU) | 1.6 (1.2ā1.9) | 3.0 (1.9ā4.2) | 0.7 (0.1ā1.3) | 0.9 (0.4ā1.4) | <0.0001 | 0.5952 | 0.2926 | <0.0001 | 0.0011 |
MSP1-19 (AU) | 0.7 (0.5ā1.0) | 1.5 (0.9ā2.0) | 0.7 (0.0ā1.4) | 0.8 (ā0.3ā1.9) | 0.0002 | 0.3937 | >0.9999 | 0.0294 | 0.0043 |
MSP3 (AU) | 1.0 (0.5ā1.4) | 2.0 (1.5ā2.6) | 1.0 (0.3ā1.7) | 0.9 (ā0.2ā2.1) | <0.0001 | 0.0141 | >0.9999 | 0.2725 | 0.0002 |
3D7 lysate (AU) | 3.5 (2.6ā4.4) | 5.2 (4.1ā6.3) | 2.3 (0.9ā3.7) | 2.4 (1.1ā3.7) | <0.0001 | 0.0423 | 0.701 | 0.003 | 0.0005 |
Prevalence of antibodies to the variant antigens (%) | Ā | Chi square test | |||||||
---|---|---|---|---|---|---|---|---|---|
N | 33 | 45 | 40 | 18 | Ā | p (A vs. B) | p (C vs. D) | p (A vs. C) | p (B vs. D) |
AMA1 | 21 (63.6) | 34 (75.6) | 5 (12.5) | 7 (38.9) | Ā | 0.2541 | 0.0217 | <0.0001 | 0.0058 |
MSP1-19 | 6 (18.2) | 17 (37.8) | 4 (10.0) | 2 (11.1) | Ā | 0.0608 | 0.8977 | 0.3116 | 0.0372 |
MSP3 | 11 (33.3) | 28 (62.2) | 9 (22.5) | 3 (16.7) | Ā | 0.0117 | 0.6119 | 0.3017 | 0.0011 |
3D7 lysate | 27 (81.8) | 44 (87.8) | 14 (35) | 9 (50.0) | Ā | 0.0148 | 0.2800 | <0.0001 | <0.0001 |